ArticleAmerican journal of preventive cardiology2026
Prediabetes, obesity and risk for incident atherosclerotic cardiovascular disease: A large-scale contemporary cohort study.
Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Structural Characterisation ofMolecules (Basel, Switzerland) · 2026Article
- Prediabetes: A precursor of diabetes and harbinger of premature CVD.American journal of preventive cardiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prediabetes is a highly prevalent metabolic state associated with the development of type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD). Early identification and management of prediabetes and obesity are critical to mitigate this risk, particularly in younger adults. However, contemporary large-scale data on the interplay of prediabetes, obesity, and cardiovascular outcomes across the adult lifespan remains limited. Methods: We conducted a retrospective cohort study of adults aged 18-90 years old within Kaiser Permanente Northern California (KPNC) from 2015-2018, excluding those with a prior history of diabetes or ASCVD. Individuals with prediabetes (HbA1c 5.7-6.4% or fasting glucose 100-125 mg/dL) were compared with those with normoglycemia. Obesity was classified based on body mass index (BMI) ≥ 30kg/m Results: The final cohort comprised 1358,882 individuals (mean age of 52.5 years; 55.8% women) of whom 688,575 (50.7%) had prediabetes at baseline. In the cohort19.2% had both prediabetes and obesity, 31.5% had prediabetes without obesity, 12.2% did not have prediabetes but had obesity, and 37.1% had neither. Over a mean follow-up period of 4.1 years, prediabetes was independently associated with a 21% increased risk of ASCVD after full adjustment (Hazard Ratio [HR] 1.21; 95% CI, 1.18-1.25). This association was strongest among younger adults (ages 18-34: HR 1.54; 95% CI, 1.18-2.02). Fully adjusted, HRs for 5-year ASCVD risk were 1.32 (95% CI 1.28-1.37) for individuals with prediabetes and obesity, and 1.22 (95% CI 1.18-1.26) for those with prediabetes without obesity, compared to the reference group without prediabetes or obesity. Conclusion: In a large, contemporary cohort study, prediabetes was independently associated with a significantly increased 5-year risk of ASCVD. The relative risk was most pronounced among young adults and those with obesity. These findings underscore a critical window for implementing targeted strategies to mitigate cardiovascular risk early during metabolic dysregulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.